PROMIS在腕管松解术患者中的反应性及其与区域和疾病特异性PROM的同期效度
这项前瞻性研究纳入70例接受腕管松解术(CTR)的患者,比较PROMIS(PF、UE、PI域)与MHQ、BCTQ的反应性和同期效度。PROMIS PI反应性最佳(ESI=0.74),UE次之(ESI=-0.66),PF无反应性;UE和PI与MHQ、BCTQ功能状态评分呈优良至优秀相关,PF相关性差。作者认为PROMIS UE和PI可用于评估CTR患者临床结局,但不推荐PROMIS PF。
要点
- PROMIS PI反应性最佳(ESI=0.74),UE次之(ESI=-0.66),PF无反应性。
- PROMIS UE和PI与MHQ、BCTQ功能状态评分呈优良至优秀相关,PF相关性差。
- 作者认为PROMIS UE和PI可用于评估CTR患者临床结局,不推荐PROMIS PF。
核心结论
- PROMIS UE和PI域的反应性略差于MHQ和BCTQ域,但仍可接受;PROMIS PF域无反应性。
- 三个PROMIS域均与MHQ和BCTQ相关,但UE和PI与MHQ和BCTQ的相关性明显强于PF。
- 作者认为PROMIS UE和PI可用于评估接受CTR患者的临床结局,同时因其为通用PROM能更全面反映整体健康状况;但不推荐PROMIS PF用于评估接受CTR的患者。
研究设计与样本
- 前瞻性研究,2014年11月至2016年10月由一位外科医生接诊并选择接受CTR的腕管综合征患者完成BCTQ、MHQ及PROMIS UE、PF、PI域问卷。
- 共101例患者同意参与,其中31例(31%)未在CTR后至少6周随访返回而被排除,最终样本为70例(69%)。
- 证据等级为II级,诊断性研究。
主要发现
- PROMIS各域中PI反应性最佳(ESI=0.74;95%CI,0.39-1.08),其次为UE(ESI=-0.66;95%CI,-1.00至-0.31)。
- MHQ中满意度域效应量最大(ESI=-1.48;95%CI,-1.85至-1.09),BCTQ中症状严重度域反应性最佳(ESI=1.54;95%CI,1.14-1.91)。
- 术前PROMIS UE与MHQ总分ρ=0.68,PI与MHQ ρ=0.74,UE与BCTQ功能状态评分ρ=0.74,PI与BCTQ功能状态评分ρ=0.67,均p<0.001。
- 术前PROMIS PF与MHQ ρ=0.33,PF与BCTQ功能状态评分ρ=0.39,均p<0.01。
关键数值与推荐
- 反应性采用Cohen's d或效应量指数(ESI)判定,ESI绝对值越大效应量越大,中等ESI(即0.5)代表细心的观察者可察觉的临床变化。
- 同期效度采用Spearman相关系数判定,相关强度分为优秀(>0.7)、优秀-良好(0.61-0.70)、良好(0.4-0.6)和差(<0.4)。
- 显著性水平事先设定为p<0.05。
临床怎么用
- 作者认为PROMIS UE和PI可用于评估接受CTR患者的临床结局,同时因其为通用PROM能更全面反映整体健康状况。
- 作者不推荐PROMIS PF用于评估接受CTR的患者。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The Patient-reported Outcome Measurement Information System (PROMIS) continues to be an important universal patient-reported outcomes measure (PROM) in orthopaedic surgery. However, there is concern about the performance of the PROMIS as a general health questionnaire in hand surgery compared with the performance of region- and condition-specific PROMs such as the Michigan Hand Questionnaire (MHQ) and the Boston Carpal Tunnel Questionnaire (BCTQ), respectively. To ensure that PROMIS domains capture patient-reported outcomes to the same degree as region- and condition-specific PROMs do, comparing PROM performance is necessary. QUESTIONS/PURPOSES: (1) Which PROMs demonstrate high responsiveness among patients undergoing carpal tunnel release (CTR)? (2) Which of the PROMIS domains (Physical Function [PF], Upper Extremity [UE], and Pain Interference [PI]) demonstrate concurrent validity with the HHQ and BCTQ domains? METHODS: In this prospective study, between November 2014 and October 2016, patients with carpal tunnel syndrome visiting a single surgeon who elected to undergo CTR completed the BCTQ, MHQ, and PROMIS UE, PF, and PI domains at each visit. A total of 101 patients agreed to participate. Of these, 31 patients (31%) did not return for a followup visit at least 6 weeks after CTR and were excluded, leaving a final sample of 70 patients (69%). We compared the PROMIS against region- and condition-specific PROMs in terms of responsiveness and concurrent validity. Responsiveness was determined using Cohen's d or the effect-size index (ESI). The larger the absolute value of the ESI, the greater the effect size. Using the ESI allows surgeons to better quantify the impact of CTR, with a medium ESI (that is, 0.5) representing a visible clinical change to a careful observer. Concurrent validity was determined using Spearman's correlation coefficient with correlation strengths categorized as excellent (> 0.7), excellent-good (0.61-0.70), good (0.4-0.6), and poor (< 0.4). Significance was set a priori at p < 0.05. RESULTS: Among PROMIS domains, the PI demonstrated the best responsiveness (ESI = 0.74; 95% CI, 0.39-1.08), followed by the UE (ESI = -0.66; 95% CI, -1.00 to -0.31). For the MHQ, the Satisfaction domain had the largest effect size (ESI = -1.48; 95% CI, -1.85 to -1.09), while for the BCTQ, the Symptom Severity domain had the best responsiveness (ESI = 1.54; 95% CI, 1.14-1.91). The PROMIS UE and PI domains demonstrated excellent-good to excellent correlations to the total MHQ and BCTQ-Functional Status scores (preoperative UE to MHQ: ρ = 0.68; PI to MHQ: ρ = 0.74; UE to BCTQ-Functional Status: ρ = 0.74; PI to BCTQ-Functional Status: ρ = 0.67; all p < 0.001), while the PROMIS PF demonstrated poor correlations with the same domains (preoperative PF to MHQ; ρ = 0.33; UE to BCTQ-Functional Status: ρ = 0.39; both p < 0.01). CONCLUSIONS: The PROMIS UE and PI domains demonstrated slightly worse responsiveness than the MHQ and BCTQ domains that was nonetheless acceptable. The PROMIS PF domain was unresponsive. All three PROMIS domains correlated with the MHQ and BCTQ, but the PROMIS UE and PI domains had notably stronger correlations to the MHQ and BCTQ domains than the PF domain did. We feel that the PROMIS UE and PI can be used to evaluate the clinical outcomes of patients undergoing CTR, while also providing more robust insight into overall health status because they are general PROMs. However, we do not recommend the PROMIS PF for evaluating patients undergoing CTR. LEVEL OF EVIDENCE: Level II, diagnostic study.
引用
- Bernstein DN, Houck JR, Mahmood B, et al. Responsiveness of the PROMIS and its Concurrent Validity with Other Region- and Condition-specific PROMs in Patients Undergoing Carpal Tunnel Release. Clin Orthop Relat Res. 2019. PMID: 31107341. doi:10.1097/CORR.0000000000000773
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。